Clinical trials
Terminated Phase 1/2 Fallopian Tube Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 18 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 2 |
| Pfizer | 2 |
| Abramson Cancer Center at Penn Medicine | 1 |
| Avenge Bio, Inc | 1 |
| Dana-Farber Cancer Institute | 1 |
| Elucida Oncology | 1 |
| Fox Chase Cancer Center | 1 |
| Incyte Corporation | 1 |
| Inge Marie Svane | 1 |
| Masonic Cancer Center, University of Minnesota | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fallopian Tube Neoplasms | 18 |
| Ovarian Neoplasms | 16 |
| Carcinoma, Ovarian Epithelial | 7 |
| Carcinoma | 2 |
| Triple Negative Breast Neoplasms | 2 |
| Adenocarcinoma, Mucinous | 1 |
| Breast Neoplasms | 1 |
| Breast Neoplasms, Male | 1 |
| Carcinoma, Endometrioid | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.